Hospice Care- A Part Of Tanner Medicare Approved Location: 150 Henry Burson Drive, Suite 102, Carrollton, Georgia 30117 Phone: (770) 214-2355 |
News Archive
Reporting in Nature, scientists from Thomas Jefferson University have determined that a single protein called FADD controls multiple cell death pathways, a discovery that could lead to better, more targeted autoimmune disease and cancer drugs.
Researchers at Baylor College of Medicine and Roche NimbleGen Inc., a fully integrated part of Roche Applied Science, have published details of a highly efficient and cost-effective method for capturing targeted regions of the genome via NimbleChip microarrays in preparation for high-throughput 454 Sequencing.
Synta Pharmaceuticals Corp. - Ganetespib, a potent, second generation Hsp90 inhibitor, has demonstrated clinical activity in heavily pre-treated patients with HER2-positive and triple negative metastatic breast cancer according to Phase 2 clinical trial results presented by researchers from Memorial Sloan-Kettering Cancer Center at the San Antonio Breast Cancer Symposium.
The results of the international, multicenter, Phase 3 RADIANT-4 study clearly demonstrate the efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or gastrointestinal origin.
Senate health committee Chairman Tom Harkin, D-Iowa, asked four of the nations largest health insurers - Aetna, Humana, Wellpoint and UnitedHealth - to explain their pricing policies after small-business owners testified Tuesday that insurance premiums were crushing their businesses, the Des Moines Register reports.
› Verified 7 days ago